We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
PolyPeptide News Flash, #1, 2021
28 Jan 2021 - Get to know Christelle Bobier, Director Global Engineering and Manufacturing Technology, in our newsletter. PolyPeptide Group maintained a strong and healthy pipeline that has gained a […]
Read moreTherapeutic indications for the PolyPeptide Group pipeline projects 2020
28 Jan 2021 - PolyPeptide Group is proud to report double-digit growth for its pipeline projects. PolyPeptide Group maintained a strong and healthy pipeline that has gained a significant growth […]
Read moreNew in-silico development tools support more efficient process design
8 Dec 2020 - The Polypeptide Group has developed a set of tools using Ypso-Proxima® software. They help make the most efficient choices at an early stage. The field of […]
Read morePolyPeptide News Flash, #3, 2020
17 Sep 2020 - The PolyPeptide Group is working on projects with clients developing peptide-based therapies and vaccines to combat COVID-19. As a Global Leader in Peptide Manufacturing and Development, […]
Read moreCapacity Expansion through Investment and Innovation
17 Sep 2020 - We have made considerable investments in scale capacities to satisfy the needs of our customers from early stage development to commercial production. Considering the continuous growth […]
Read moreMinimizing HCN in DIC/Oxyma-Mediated Amide Bond-Forming Reactions
15 Jun 2020 - Aiming at advancing protocols for safer, environmentally sensible peptide synthesis we report our findings with regard to the occurrence of hydrogen cyanide (HCN, prussic acid) in amide bond-forming reactions mediated by diisopropylcarbodiimide (DIC) and ethyl (hydroxyimino)cyanoacetate (Oxyma).[…]
Read morePolyPeptide Group Selected by Novavax to Manufacture Critical Intermediates of Matrix-M™ Adjuvant for its COVID-19 Vaccine
4 Jun 2020 - The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax […]
Read morePolyPeptide News Flash, #2, 2020
12 May 2020 - While the COVID-19 crisis continues, the PolyPeptide Group is actively engaged in helping find treatments and vaccines for COVID-19. While the COVID-19 crisis continues, the PolyPeptide […]
Read moreInformation Letter on COVID-19
23 Apr 2020 - Our company is actively engaged in helping to find treatments and cures for COVID-19. Dear Valued Customer, While the COVID-19 crisis continues, I want to assure […]
Read more